Healthtech Investors & VC Firms in United States
2758 firms in this list, with a median first check of $500K. 731 of them lead rounds. Generated from verified public data and updated continuously.
Recursion Pharmaceuticals
Salt Lake CitySeed
18 people
Surface Ventures
New YorkPre-Seed–Seed$500K – $3M
3 people
Horowitz Family Office
Newport BeachSeed
8 people
Recode Ventures
San FranciscoSeed–Series A
8 people
Saba Investments
El PasoPre-Seed–Series A$200K
8 people
Boom Capital Ventures
San FranciscoPre-Seed–Seed$50K – $300K
2 people
Red Bike Capital
New YorkPre-Seed–Seed$25K – $1M
2 people
SV Latam Capital
San FranciscoSeed–Series A$50K – $500K
2 people
1616 Ventures
New YorkPre-Seed–Seed$50K – $100K
4 people
KIC Ventures
Fort LauderdaleGrowth–Late Stage
10 people
Belal Badat Ventures
San FranciscoPre-Seed–Growth$300K – $500K
3 people
Belle Impact Fund
Grosse Pointe FarmsSeed–Series A$25K – $250K
3 people
GPO Fund
New YorkSeries C–Growth$5M – $10M
6 people
Inoca Capital
Park CityGrowth
9 people
Root and Shoot Ventures
Los AngelesPre-Seed–Seed
3 people
SUVAN VENTURES
CupertinoSeed–Series A$200K – $400K
3 people
7G BioVentures
Burlingame
5 people
CloudStone Capital
San MateoSeed–Series A
5 people
Northwestern Medicine Innovation, LLC
ChicagoSeed–Series A
11 people
Security Leadership Capital
San JoseSeed$100K – $5M
5 people
VIEWPOINT VENTURES
New YorkSeries B–Late Stage
8 people
Banyan Ventures
New YorkPre-Seed–Series A
2 people
Cobalt Ventures
Kansas CitySeries A–Series B$10M – $75M
2 people
Attack Capital
BrooklynPre-Seed–Series A$150K
4 people
Related lists
Investors & VC Firms in North America (13326)Investors & VC Firms in United States (12318)Investors & VC Firms in Europe (6083)AI & Machine Learning Investors & VC Firms (5352)Investors & VC Firms in Global (5318)Fintech Investors & VC Firms (5140)Healthtech Investors & VC Firms (4657)SaaS Investors & VC Firms (4528)Enterprise Software Investors & VC Firms (4424)Crypto & Web3 Investors & VC Firms (4140)
Data sourced from public filings and firms' own websites — see our methodology.

















































































